UBS ASSET MANAGEMENT AMERICAS LLC - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 90 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 11.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$188,358,000
-54.8%
38,917
-0.7%
0.00%
Q4 2019$416,803,000
+27.2%
39,210
+24.6%
0.00%
Q3 2019$327,551,000
+20.2%
31,465
+76.9%
0.00%
Q2 2019$272,497,000
+19.2%
17,7870.0%0.00%
Q1 2019$228,563,000
+12762.3%
17,787
+9411.8%
0.00%
Q4 2018$1,777,000
-42.8%
1870.0%0.00%
Q3 2018$3,104,000
+3.4%
1870.0%0.00%
Q2 2018$3,001,0001870.00%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q2 2018.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders